Scott Kendrick, MD
Nephrology · Greenville, NCNPI 1104042365
Payments from drug & device makers
Across 92 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$299
- AstraZeneca$294
- Amgen$237
- Nxstage Medical, Inc.$135
- MML US, Inc.$127
- Otsuka America Pharmaceutical, Inc.$126
- plus $883 from 22 others
What the payments were for
- Travel & lodging$29914%
- Food & beverage$1,75684%
- Education$462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 4 | $299 |
| AstraZeneca(2 entities) | 12 | $294 |
| Amgen(2 entities) | 14 | $237 |
| Nxstage Medical, Inc. | 1 | $135 |
| MML US, Inc. | 1 | $127 |
| Otsuka America Pharmaceutical, Inc. | 8 | $126 |
| OPKO Pharmaceuticals, LLC | 6 | $87 |
| GSK | 5 | $86 |
| Fresenius USA Marketing, Inc. | 4 | $60 |
| Vifor Pharma, Inc. | 4 | $59 |
| Merck | 4 | $59 |
| Nevro Corp. | 1 | $58 |
| Akebia Therapeutics Inc | 3 | $57 |
| Boston Scientific | 3 | $42 |
| Travere Therapeutics, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $38 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Bayer | 2 | $33 |
| Novartis | 2 | $33 |
| Assertio Therapeutics, Inc. | 2 | $29 |
| Biomerieux Inc | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Calliditas Therapeutics US Inc. | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$262
- LIBERTY SELECT CYCLER$135
- NXSTAGE SYSTEM ONE$135
- ReActiv8$127
- FARXIGA$125
How this compares
$2,101 in reported general payments places this provider in the 55th percentile of 366 nephrology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 80 | $64,859 |
| RayaldeeCalcifediol | 26 | $36,255 |
| JardianceEmpagliflozin | 37 | $28,263 |
| Cinacalcet Hcl | 70 | $25,077 |
| EliquisApixaban | 24 | $13,923 |
| Valganciclovir Hcl | 35 | $5,727 |
| Carvedilol ErCarvedilol Phosphate | 14 | $3,117 |
| Sevelamer Carbonate | 22 | $2,932 |
| Methenamine Hippurate | 58 | $2,463 |
| Famotidine | 317 | $2,442 |
| Bumetanide | 57 | $2,241 |
| Rosuvastatin Calcium | 71 | $1,533 |
| Carvedilol | 194 | $1,463 |
| Calcium Acetate | 18 | $1,258 |
| Pantoprazole Sodium | 59 | $1,175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $294 | $64,85980 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $87 | $36,25526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 366 nephrology providers in North Carolina.
Other nephrology in Greenville
- Nauman ShahidGreenville$2M
- Cynthia ChristianoGreenville$494K
- Reginald ObiGreenville$328K
- Paul BolinGreenville$227K
- William KendrickGreenville$125K
- Daniel EdmonstonDurham$9.9M
- Gregory GreenwoodWinston-Salem$4.1M
- Barry FreedmanWinston Salem$3.5M
- Manuel MonteroNew Bern$2.5M
- Rekha JohnKinston$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.